The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemia

The histone methyltransferase EZH2 induces gene repression through trimethylation of histone H3 at lysine 27 (H3K27me3). EZH2 overexpression has been reported in many types of cancer and associated with poor prognosis. Here we investigated the expression and functionality of EZH2 in chronic lymphocy...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Papakonstantinou, Nikos, Ntoufa, Stavroula, Chartomatsidou, Elisavet, Kotta, Konstantia, Agathangelidis, Andreas, Giassafaki, Lefki, Karamanli, Tzeni, Bele, Panagiota, Moysiadis, Theodoros, Baliakas, Panagiotis, Sutton, Lesley Ann, Stavroyianni, Niki, Anagnostopoulos, Achilles, Makris, Antonios M., Ghia, Paolo, Rosenquist, Richard, Stamatopoulos, Kostas
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2016
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5094974/
https://ncbi.nlm.nih.gov/pubmed/27191993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9371
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak